International consensus on the prevention of venous and arterial thrombotic events in patients with inflammatory bowel disease.
Ontology highlight
ABSTRACT: Patients with inflammatory bowel disease (IBD) are at increased risk of thrombotic events. Therapies for IBD have the potential to modulate this risk. The aims of this Evidence-Based Guideline were to summarize available evidence and to provide practical recommendations regarding epidemiological aspects, prevention and drug-related risks of venous and arterial thrombotic events in patients with IBD. A virtual meeting took place in May 2020 involving 14 international IBD experts and 3 thrombosis experts from 12 countries. Proposed statements were voted upon in an anonymous manner. Agreement was defined as at least 75% of participants voting as 'fully agree' or 'mostly agree' with each statement. For each statement, the level of evidence was graded according to the Scottish Intercollegiate G
SUBMITTER: Olivera PA
PROVIDER: S-EPMC8395387 | biostudies-literature | 2021 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA